Broadview Ventures ^Investors

Broadview Ventures is an organization that invests in businesses focused on developing technology solutions for cardiovascular and neurovascular diseases. Established in 2008, Broadview Ventures aims to accelerate the development of promising technology in these fields through targeted investments and support of early-stage technology ventures. The organization is supported by the Foundation Leducq, a charitable trust based in Paris, France, which provides funds for Broadview to promote early-stage technology in cardiovascular and neurovascular disease. Broadview Ventures has invested in companies like Cardiosense, which is developing an AI platform for the diagnosis and management of cardiovascular disease, and Comanche Biopharma, which is developing a novel siRNA therapy for preeclampsia.